Page last updated: 2024-11-04

sulmazole and Acute Disease

sulmazole has been researched along with Acute Disease in 2 studies

sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"2-[(2-Methoxy-4-methylsulfinyl)phenyl]-1H-imidazo [4,5-b]pyridine (AR-L 115 BS) in a single dosage of 0."1.26Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction. ( Nebel, W; Sabin, G; Surawitzki, G, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagemeijer, F1
Segers, A1
Schelling, A1
Nebel, W1
Sabin, G1
Surawitzki, G1

Other Studies

2 other studies available for sulmazole and Acute Disease

ArticleYear
Cardiovascular effects of sulmazol administered intravenously to patients with severe heart failure.
    European heart journal, 1984, Volume: 5, Issue:2

    Topics: Acute Disease; Adult; Aged; Cardiotonic Agents; Coronary Circulation; Female; Heart Failure; Hemodyn

1984
Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:1a

    Topics: Acute Disease; Blood Pressure; Cardiotonic Agents; Heart Rate; Hemodynamics; Humans; Imidazoles; Myo

1981